Terms: = Pancreatic cancer AND CDK4, PSK-J3, 1019, ENSG00000135446, MGC14458, CMM3, P11802 AND Diagnosis
27 results:
1. CDKN2A/cdk4 status in Brazilian patients meeting clinical criteria for hereditary melanoma: a cross-sectional descriptive trial.
Arnaut JRMB; Guimarães IDS; Dos Santos ACE; Rodrigues EM; Machado JRDS; de Melo AC
Int J Dermatol; 2023 Aug; 62(8):1060-1066. PubMed ID: 37322831
[TBL] [Abstract] [Full Text] [Related]
2. Clonal evolution during metastatic spread in high-risk neuroblastoma.
Gundem G; Levine MF; Roberts SS; Cheung IY; Medina-Martínez JS; Feng Y; Arango-Ossa JE; Chadoutaud L; Rita M; Asimomitis G; Zhou J; You D; Bouvier N; Spitzer B; Solit DB; Dela Cruz F; LaQuaglia MP; Kushner BH; Modak S; Shukla N; Iacobuzio-Donahue CA; Kung AL; Cheung NV; Papaemmanuil E
Nat Genet; 2023 Jun; 55(6):1022-1033. PubMed ID: 37169874
[TBL] [Abstract] [Full Text] [Related]
3. First diagnosed invasive lobular carcinoma of the breast combined with gastric metastasis and bone metastasis: a case report and review of the literature.
Sun L; Liu J; Guo M; Xu J; Wang D
BMC Womens Health; 2023 Mar; 23(1):133. PubMed ID: 36966290
[TBL] [Abstract] [Full Text] [Related]
4. Tumor-suppressive role of microfibrillar associated protein 4 and its clinical significance as prognostic factor and diagnostic biomarker in hepatocellular carcinoma.
Li J; Wang J; Liu Z; Guo H; Wei X; Wei Q; Zheng S; Xu X
J Cancer Res Ther; 2022 Dec; 18(7):1919-1925. PubMed ID: 36647950
[TBL] [Abstract] [Full Text] [Related]
5. Implication of ERBB2 as a Predictive Tool for Survival in Patients with pancreatic cancer in Histological Studies.
Ortega MA; Pekarek L; Fraile-Martinez O; Garcia-Montero C; Saez MA; Asúnsolo A; Alvarez-Mon MA; Monserrat J; Ruiz-Llorente L; García-Honduvilla N; Albillos A; Buján J; Alvarez-Mon M; Guijarro LG
Curr Oncol; 2022 Mar; 29(4):2442-2453. PubMed ID: 35448172
[TBL] [Abstract] [Full Text] [Related]
6. Characteristics, Treatment, Outcomes, and Survival in Neuroendocrine G1 and G2 pancreatic Tumors: Experiences From a Single Tertiary Referral Center.
Calissendorff J; Bjellerup-Calissendorff F; Bränström R; Juhlin CC; Falhammar H
Front Endocrinol (Lausanne); 2021; 12():657698. PubMed ID: 33927695
[TBL] [Abstract] [Full Text] [Related]
7. Epigenetic silencing of CDKN1A and CDKN2B by SNHG1 promotes the cell cycle, migration and epithelial-mesenchymal transition progression of hepatocellular carcinoma.
Li B; Li A; You Z; Xu J; Zhu S
Cell Death Dis; 2020 Oct; 11(10):823. PubMed ID: 33009370
[TBL] [Abstract] [Full Text] [Related]
8. The NETest liquid biopsy is diagnostic for gastric neuroendocrine tumors: observations on the blood-based identification of microscopic and macroscopic residual diseaseOK.
Malczewska A; Procner A; Walter A; Kusnierz K; Zajecki W; Aslanian H; Kos-Kudla B
BMC Gastroenterol; 2020 Jul; 20(1):235. PubMed ID: 32703157
[TBL] [Abstract] [Full Text] [Related]
9. The role of
Chroustova D; Trnka J; Pudlac A; Obermannova B; Lambert L
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(5):279-283. PubMed ID: 32448747
[TBL] [Abstract] [Full Text] [Related]
10. Clinical histopathological features and CDKN2A/cdk4/MITF mutational status of patients with multiple primary melanomas from Bologna: Italy is a fascinating but complex mosaic.
Dika E; Patrizi A; Rossi C; Turchetti D; Miccoli S; Ferracin M; Veronesi G; Scarfì F; Lambertini M
Ital J Dermatol Venerol; 2021 Oct; 156(5):599-605. PubMed ID: 32221274
[TBL] [Abstract] [Full Text] [Related]
11. Long noncoding RNA EPIC1 interacts with YAP1 to regulate the cell cycle and promote the growth of pancreatic cancer cells.
Xia P; Liu P; Fu Q; Liu C; Luo Q; Zhang X; Cheng L; Qin T; Zhang H
Biochem Biophys Res Commun; 2020 Feb; 522(4):978-985. PubMed ID: 31810603
[TBL] [Abstract] [Full Text] [Related]
12. Management and surveillance of non-functional pancreatic neuroendocrine tumours: Retrospective review.
Yohanathan L; Dossa F; St Germain AT; Golbafian F; Moulton CA; McGilvray ID; Greig PD; Serra S; Wei AC; Jhaveri KS; Gallinger S; Cleary SP
Pancreatology; 2019 Mar; 19(2):360-366. PubMed ID: 30803874
[TBL] [Abstract] [Full Text] [Related]
13. SHCBP1 is a novel target and exhibits tumor‑promoting effects in gastric cancer.
Dong YD; Yuan YL; Yu HB; Tian GJ; Li DY
Oncol Rep; 2019 Mar; 41(3):1649-1657. PubMed ID: 30592290
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of Multislice Spiral CT Dual Phase and Somatosatatin Receptor Scintigraphy in the diagnosis of Pancreas Neuroendocrine Tumors.
Wang H; Li P; Pan WD; Xue HD
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):312-7. PubMed ID: 27469917
[TBL] [Abstract] [Full Text] [Related]
15. In vitro regulation of hepatocellular carcinoma cell viability, apoptosis, invasion, and AEG-1 expression by LY294002.
Ma J; Xie SL; Geng YJ; Jin S; Wang GY; Lv GY
Clin Res Hepatol Gastroenterol; 2014 Feb; 38(1):73-80. PubMed ID: 23910058
[TBL] [Abstract] [Full Text] [Related]
16. Calix[6]arene bypasses human pancreatic cancer aggressiveness: downregulation of receptor tyrosine kinases and induction of cell death by reticulum stress and autophagy.
Pelizzaro-Rocha KJ; de Jesus MB; Ruela-de-Sousa RR; Nakamura CV; Reis FS; de Fátima A; Ferreira-Halder CV
Biochim Biophys Acta; 2013 Dec; 1833(12):2856-2865. PubMed ID: 23872419
[TBL] [Abstract] [Full Text] [Related]
17. Net expression inhibits the growth of pancreatic ductal adenocarcinoma cell PL45 in vitro and in vivo.
Li B; Wan X; Zhu Q; Li L; Zeng Y; Hu D; Qian Y; Lu L; Wang X; Meng X
PLoS One; 2013; 8(2):e57818. PubMed ID: 23469073
[TBL] [Abstract] [Full Text] [Related]
18. History of peptic ulcer disease and pancreatic cancer risk in men.
Bao Y; Spiegelman D; Li R; Giovannucci E; Fuchs CS; Michaud DS
Gastroenterology; 2010 Feb; 138(2):541-9. PubMed ID: 19818786
[TBL] [Abstract] [Full Text] [Related]
19. Endoscopic ultrasound guided fine-needle aspiration core biopsy: comparison between an automatic biopsy device and two conventional needle systems.
Ardengh JC; Paulo GA; Nakao FS; Venco F; Santo GC; Geocze S
Acta Gastroenterol Latinoam; 2008 Jun; 38(2):105-15. PubMed ID: 18697405
[TBL] [Abstract] [Full Text] [Related]
20. Inhibition of cdk4 impairs proliferation of pancreatic cancer cells and sensitizes towards TRAIL-induced apoptosis via downregulation of survivin.
Retzer-Lidl M; Schmid RM; Schneider G
Int J Cancer; 2007 Jul; 121(1):66-75. PubMed ID: 17304504
[TBL] [Abstract] [Full Text] [Related]
[Next]
